HealthTech
Australia’s Prota Therapeutics secures $21M in financing led by SPRIM Global Investments
Prota Therapeutics Pty Ltd (Prota), an Australian biotechnology company focused on the development of novel oral immunotherapy treatments that induce remission of allergy, has on Tuesday announced financing of $21 million in equity and debt financing. The round is led by Singapore-based SPRIM Global Investments (SGI).
Entrepreneurial evolution: Redefining business models at the forefront of pharmaceutical Innovation
As the #pharmaceutical industry continues to evolve, embracing community-centric approaches could be the key to addressing the pressing challenges of today's pharmaceutical landscape. #HealthTech #BigPharma
Corrective Aesthetics partners Teda Technology to tackle Malaysia’s rising mental health crisis
In response to the escalating mental health crisis in Malaysia, tech firms Corrective Aesthetics Sdn Bhd and Teda Technology Sdn Bhd have announced a groundbreaking collaboration to expand the Remind program, a mobile application that is designed to diagnose users' mental states through voice recordings.
Navigating the landscape of novel gene therapies: How small countries can unlock the global gene therapy market
The future of #biotech investments hinges on the continued evolution of gene therapies and the integration of novel technologies into biological research standards ... In this dynamic landscape, small countries such as #Singapore and #Estonia might achieve catalyzing potential by providing relevant, consistent, and innovation-driven regulatory frameworks to…
India’s PlasmaGen Biosciences completes $27M equity financing
PlasmaGen Biosciences, a biopharmaceutical company focused on blood plasma-derived pharmaceutical products for India and emerging markets, announced that it has raised 225 crores ($27 million) in equity financing. The funding was coming from United Kingdom based Artian Investments, prominent public market investor Ashish Kacholia, pharmaceutical…
Australian health tech company Vantari VR raises $4.7M in funding led by Co:Act Capital
Australia-based virtual reality (VR) medical training provider Vantari VR, has secured AUD $7 million ($4.7 million) via a Pre Series A capital raise. The oversubscribed round was led by Co:Act Capital and supported by Acova Capital, Significant Early Venture Capital, Sirius Capital and other investors from the medical device and insurance ecosystem.
Singapore’s Sweef Capital makes strategic investment in Vietnam’s USM Healthcare
Singapore investment firm Sweef Capital has made strategic investment in Vietnam-based USM Healthcare to increase access to affordable medical devices and orthopedic products.
Indonesian healthtech firm Klinik Pintar closes $5M round led by Altara Ventures
Jakarta-headquartered healthtech company Klinik Pintar has announced an oversubscribed $5 million Series A1 funding round led by Altara Ventures. The round also saw participation from leading healthcare information technology (IT) corporate, Infocom, and existing investors Golden Gate Ventures, Skystar Capital and Venturra.
Singapore’s Doctor Anywhere attracts $40.8M in fresh funding to scale healthcare innovation
Doctor Anywhere, a tech-led healthcare company headquartered in Singapore, has on Thursday announced a $40.8 million Series C1 extension round with participating investors including Square Peg and Novo Holdings. The influx of funds will be directed to strategically drive next-generation healthcare innovation within the company, and to deepen its presence…
Singapore’s MiyaHealth obtains ISO certification and CE mark for its chronic disease management platform
MiyaHealth, a Singapore-headquartered global software as a service (SaaS) HealthTech, has announced that it has secured ISO 13845:2016 certification and a CE Mark for GensuApp, its chronic disease management platform created in partnership with Bioton S.A., a Poland-based biotech company.
